logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Mr Ian Jacobson
    Born in March 1960
    Individual (12 offsprings)
    Person with significant control
    icon of calendar 2021-11-16 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 2
    Podolsky, Craig
    Born in February 1981
    Individual (10 offsprings)
    Officer
    icon of calendar 2021-11-16 ~ now
    OF - Director → CIF 0
  • 3
    Fraser-pye, Graham Julian
    Born in March 1968
    Individual (17 offsprings)
    Officer
    icon of calendar 2022-05-07 ~ now
    OF - Director → CIF 0
parent relation
Company in focus

CORAM PHARMA LIMITED

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
53,965 GBP2024-12-31
53,885 GBP2023-12-31
Cash at bank and in hand
226,630 GBP2024-12-31
395,017 GBP2023-12-31
Current Assets
280,595 GBP2024-12-31
448,902 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-31,539 GBP2024-12-31
Net Current Assets/Liabilities
249,056 GBP2024-12-31
-487,100 GBP2023-12-31
Equity
Called up share capital
11,067 GBP2024-12-31
3,617 GBP2023-12-31
Share premium
1,085,634 GBP2024-12-31
348,084 GBP2023-12-31
Retained earnings (accumulated losses)
-847,645 GBP2024-12-31
-838,801 GBP2023-12-31
Equity
249,056 GBP2024-12-31
-487,100 GBP2023-12-31
Average Number of Employees
02024-01-01 ~ 2024-12-31
02023-01-01 ~ 2023-12-31
Other Debtors
Amounts falling due within one year
53,965 GBP2024-12-31
53,885 GBP2023-12-31
Other Creditors
Current
31,539 GBP2024-12-31
936,002 GBP2023-12-31
Par Value of Share
Class 1 ordinary share
0 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
48,500 shares2024-12-31
48,500 shares2023-12-31
Par Value of Share
Class 2 ordinary share
0 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
48,500 shares2024-12-31
48,500 shares2023-12-31
Par Value of Share
Class 3 ordinary share
0 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
3,000 shares2024-12-31
3,000 shares2023-12-31

  • CORAM PHARMA LIMITED
    Info
    Registered number 13747003
    icon of addressFlint Barn, Harrow Lane, Petersfield, Hampshire GU32 2HT
    PRIVATE LIMITED COMPANY incorporated on 2021-11-16 (4 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2024-11-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.